FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

BACKGROUND: FOLFOX chemotherapy is one of the most commonly used treatments for colorectal cancer (CRC) patients. However, the efficacy and tolerance of FOLFOX therapy varies between patients. The purpose of this study was to explore hub genes associated with primary chemotherapy-resistance and to e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Genet
Päätekijät: Zhang, Yiyi, Sun, Lijun, Wang, Xiaojie, Sun, Yanwu, Chen, Ying, Xu, Meifang, Chi, Pan, Lu, Xingrong, Xu, Zongbin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Genetics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078371/
https://ncbi.nlm.nih.gov/pubmed/32218799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00113
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia